To evaluate the stemness role in ITAC prognosis, we analyzed, for the first time, the expressions of the Yamanaka factors KLF4, c-MYC, SOX2, OCT4, and NANOG in a cohort of patients with ITAC and investigate their possible roles in influencing tumor properties and survival. This evidence concerns the gene KLF4 and neoplasm.